Search

Your search keyword '"Seisen, T"' showing total 547 results

Search Constraints

Start Over You searched for: Author "Seisen, T" Remove constraint Author: "Seisen, T"
547 results on '"Seisen, T"'

Search Results

7. Recommandations du Comité de cancérologie de l’Association Française d’Urologie (CC-AFU) pour la bonne pratique des instillations intravésicales de mitomycine C, d’épirubicine et de BCG pour le traitement des tumeurs de la vessie n’infiltrant pas le muscle (TVNIM)

10. Evaluation of the long term recurrence risk, metastatic potential and length of cystoscopic surveillance of low-grade non-muscle invasive bladder cancer

11. Consistencies in follow-up after radical cystectomy for bladder cancer: A practice-based framework by collaborative EAU bladder cancer guideline panels

12. Individual patient data validation of the definitions of BCG failure in patients with non-muscle invasive urothelial carcinoma of the bladder: An international multi-centre retrospective study

20. Impact pronostique de l’expression de pd-1 et pd-l1 pour les tumeurs de la voie excrétrice supérieure

23. Does a positive multi-parametric MRI always warrant prostate biopsy? the importance of integrating clinical and imaging data based on a large, multi-institutional series

24. Can low risk disease outside the index lesion be left untreated in men suitable for focal therapy? development of novel criteria to identify potential candidates for focal therapy among patients with intermediate risk prostate cancer and positive multi-parametric MRI

25. Detection of clinically significant prostate cancer in mpMRI visible lesions: size matters. Results from a large, two-institutional series

28. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

39. Assessing the impact of BCG on progression of NMIBC in the new EAU high risk and very high-risk groups

40. Detection of clinically significant prostate cancer in mpMRI visible lesions: Size matters. Results from a large, two-institutional series

41. Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer

42. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

45. Introducing PIONEER: a project to harness big data in prostate cancer research

46. Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research (Nature Reviews Urology, (2020), 17, 6, (351-362), 10.1038/s41585-020-0324-x)

47. Development and external validation of a novel tool predicting lymph node invasion in patients with prostate cancer detected at targeted-biopsies

48. Saturation of the MPMRI lesion is not necessary to minimize the risk of missing clinically significant prostate cancer at targeted biopsy. Analysis of a large, multi-institutional series

49. Identifying the optimal clinical setting for the use of multiparametric magnetic resonance imaging of the prostate as local staging tool in men candidate to radical prostatectomy. Results from a multi-institutional series

Catalog

Books, media, physical & digital resources